Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLR2007 in advanced solid tumors
NCT04444427Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crozbaciclib in solid tumor (advanced stage), non-small cell lung cancer (NSCLC), glioblastoma (GBM), breast cancer, sponsored by Gan & Lee Pharmaceuticals. Started Jul 2020; status: completed.
02
Drugs
crozbaciclib
03
Conditions
solid tumor (advanced stage)non-small cell lung cancer (NSCLC)glioblastoma (GBM)breast cancer
Beyond the preview
Go deeper on NCT04444427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444427.